Status: Recruiting
Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
This study aims to evaluate the effect of sacubitril/valsartan in patients with prosthetic heart valves with heart failure with reduced ejection fraction (HFrEF).
Participants needed: 220
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Kafrelsheikh UniversityUpdated: Sep 30, 2025Locations: 1
Eligibility criteria
Age ≥ 18 years old. [+3]
Hemodynamic instability. [+9]